Restricted accessLetterFirst published online 2012-9
Serotonin 1A receptors in the action of antipsychotic drugs: comment on ‘Measurement of the serotonin 1A receptor availability in patients with schizophrenia during treatment with the antipsychotic medication ziprasidone’ by Frankle et al. 2011;25(6): 734–743
ArakiTYamasueHSumiyoshiT. (2006) Perospirone in the treatment of schizophrenia: effect on verbal memory organization. Prog Neuropsychopharmacol Biol Psychiatry30: 204–208.
2.
BortolozziAMasanaMDiaz-MataixL. (2010) Dopamine release induced by atypical antipsychotics in prefrontal cortex requires 5-HT(1A) receptors but not 5-HT(2A) receptors. Int J Neuropsychopharmacol13: 1299–1314.
3.
Diaz-MataixLScorzaMCBortolozziA. (2005) Involvement of 5-HT1A receptors in prefrontal cortex in the modulation of dopaminergic activity: role in atypical antipsychotic action. J Neurosci25: 10831–10843.
4.
FrankleWGLombardoIKegelesLS. (2011) Measurement of the serotonin 1A receptor availability in patients with schizophrenia during treatment with the antipsychotic medication ziprasidone. J Psychopharmacol25: 734–743.
5.
HiguchiYSumiyoshiTKawasakiY. (2010) Effect of tandospirone on mismatch negativity and cognitive performance in schizophrenia: a case report. J Clin Psychopharmacol30: 732–734.
6.
Llado-PelfortLSantanaNGhisiV. (2012) 5-HT1A receptor agonists enhance pyramidal cell firing in prefrontal cortex through a preferential action on GABA interneurons. Cerebral Cortex22: 1487–1497.
7.
MatsuiMSumiyoshiTYuukiH. (2006) Impairment of event schema in patients with schizophrenia: examination of script for shopping at supermarket. Psychiatry Res143: 179–187.
8.
MeltzerHYSumiyoshiT. (2008) Does stimulation of 5-HT(1A) receptors improve cognition in schizophrenia?Behav Brain Res195: 98–102.
9.
Newman-TancrediAKlevenMS (2011) Comparative pharmacology of antipsychotics possessing combined dopamine D2 and serotonin 5-HT1A receptor properties. Psychopharmacology216: 451–473.
10.
SirotaPEpsteinBBenatovR. (2001) An open study of buspirone augmentation of neuroleptics in patients with schizophrenia. J Clin Psychopharmacol21: 454–455.
11.
SumiyoshiTHiguchiYItohT. (2009) Effect of perospirone on P300 electrophysiological activity and social cognition in schizophrenia: a three-dimensional analysis with sloreta. Psychiatry Res172: 180–183.
12.
SumiyoshiTHiguchiYMatsuiM. (2007a) Effective adjunctive use of tandospirone with perospirone for enhancing verbal memory and quality of life in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry31: 965–967.
13.
SumiyoshiTMatsuiMNoharaS. (2001a) Enhancement of cognitive performance in schizophrenia by addition of tandospirone to neuroleptic treatment. Am J Psychiatry158: 1722–1725.
14.
SumiyoshiTMatsuiMYamashitaI. (2001b) The effect of tandospirone, a serotonin(1A) agonist, on memory function in schizophrenia. Biol Psychiatry49: 861–868.
15.
SumiyoshiTParkSJayathilakeK. (2007b) Effect of buspirone, a serotonin1A partial agonist, on cognitive function in schizophrenia: a randomized, double-blind, placebo-controlled study. Schizophr Res95: 158–168.
16.
SumiyoshiTStockmeierCAOverholserJC. (1996) Serotonin1A receptors are increased in postmortem prefrontal cortex in schizophrenia. Brain Res708: 209–214.
